Skip to content

CalAmp CAMP Earnings yield

Earnings yield at other companies

Ionis Pharmaceuticals logo
Ionis PharmaceuticalsIONS
-2.6%-1.1pp
Stoke Therapeutics, Inc. logo
Stoke Therapeutics, Inc.STOK
-8.8%-22.8pp
Rapport Therapeutics, Inc. logo
Rapport Therapeutics, Inc.RAPP
-7.2%-2.9pp
MeiraGTx Holdings plc logo
MeiraGTx Holdings plcMGTX
-25.5%
Taysha Gene Therapies, Inc. logo
Taysha Gene Therapies, Inc.TSHA
-10.1%-4.0pp
CytomX Therapeutics logo
CytomX TherapeuticsCTMX
-5.8%-87.5pp

Other financials

Income statement

See full
Revenue$1.3M+50.8%
Operating income-$13.1M+0.2%
Net income-$18.3M-47.4%
EPS (diluted)-$0.32+48.4%

Balance sheet

See full
Cash & equivalents$100.8M+97.9%
Total debt$2.1M-73.2%
Total equity$30.9M-40.1%
Total assets$105.5M+68.0%

Cash flow

See full
Operating cash flow-$11.0M+23.1%
CapEx--100%
Free cash flow-$11.0M+24.6%

Valuation

See full
Market cap$226.92M+666%
Enterprise value$128.2M-3,860%
P/S57.7×+47.8×

Profitability

See full
Operating margin-1,335.2%-512pp
Net margin-2,193.7%-581pp
FCF margin-1,254%

Returns & leverage

See full
Return on equity-209.3%
Debt / equity0.1×-0.1×
Current ratio6.1×-1.9×

Where this comes from

Calculated from CalAmp’s reported figures.

Based on trailing twelve months.

The official record: CalAmp’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about CalAmp's earnings yield.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is CalAmp's earnings yield?
CalAmp (CAMP) reported earnings yield of -37.7% in Q1 2026.
How has CalAmp's earnings yield changed year-over-year?
CalAmp's earnings yield increased by 41.3% year-over-year, from -64.2% to -37.7%.
What does earnings yield mean?
Trailing-twelve-month net income divided by market capitalization at the quarter end — the inverse of the P/E ratio, expressed as a percentage.